SCHEMBL22019949

SCHEMBL22019949

CC(C)(O)c1ccc(SN)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.37
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
GAA P10253 1/20 0.34
MAPT P10636 1/20 0.34
PKM P14618 1/20 0.34
RECQL P46063 1/20 0.34
MLYCD O95822 1/20 0.34
HSD11B1 P28845 1/20 0.34
LMNA P02545 1/20 0.32
TYR P14679 1/20 0.32
ESR1 P03372 1/20 0.32
CYP3A4 P08684 1/20 0.32
AR P10275 1/20 0.32
HPGD P15428 1/20 0.32
TSHR P16473 1/20 0.32
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32
HTR6 P50406 1/20 0.32
ESRRG P62508 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7127307 0.80 MLYCD (0.50) ALDH1A1MEN1KMT2AGAAMAPT
SCHEMBL5043657 0.80 ALDH1A1 (0.48) ALDH1A1MEN1KMT2AGAAMAPT
SCHEMBL196799 0.79 MEN1 (0.48) ALDH1A1MEN1KMT2AHSD11B1LMNA
SCHEMBL24596801 0.73 HSD11B1 (0.33) ALDH1A1MEN1KMT2AMLYCDHSD11B1
SCHEMBL24592519 0.73 CYP11B1 (0.30)
SCHEMBL5591445 0.72 PDE2A (0.50) ALDH1A1MEN1KMT2AGAAMAPT
SCHEMBL780699 0.72 ALDH1A1 (0.48) ALDH1A1MEN1KMT2AGAAMAPT
SCHEMBL18802754 0.71 KIF11 (0.44) MEN1KMT2AHSD11B1LMNATYR
SCHEMBL4850356 0.71 ESR1 (0.60) ALDH1A1MEN1KMT2ARECQLHSD11B1
SCHEMBL10620533 0.71 LMNA (0.60) ALDH1A1MEN1KMT2AGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3445756-B1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS AG (CH) 2022-07-06 EP disclosed
WO-2020102096-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-05-22 WO disclosed